{"title":"草甘膦途径与现代疾病VI:朊病毒,淀粉样病变和自身免疫性神经疾病","authors":"Anthony Samsel, S. Seneff","doi":"10.4024/25SA16A.JBPC.17.01","DOIUrl":null,"url":null,"abstract":"At first glance, multiple sclerosis (MS) and autism appear to have little in common, aside from the fact that both are neurological diseases. Autism is a condition with prenatal or early childhood onset, characterized by repetitive behaviours, impaired social interaction and cognitive impairment. The male:female ratio for autism is 4:1, while multiple sclerosis is twice as common in women as in men; its first symptoms usually begin in early adulthood to involve impaired lower limb mobility, although in later stages it affects both mental and physical capabilities. Both conditions are, however, associated with inflammatory autoimmune features [1, 2], and both diseases are viewed as having an environmental and a genetic component [3–6]. A study comparing a population of 658 MS patients with the general population found an association between MS and increased rates of asthma, inflammatory bowel disease (IBD), type 1 diabetes mellitus, pernicious anaemia and autoimmune thyroid disease [7], all of which have also been linked to autism [8–11]. These conditions are all considered to be autoimmune diseases, which can be triggered through molecular mimicry, where an antibody responding to a foreign protein that resembles a native protein becomes sensitized to the native protein as well [12]. A paper by Shoenfeld and Aron-Maor in 2000 developed the argument that both autism and MS may be examples of an autoimmune reaction via mimicry following exposure to an antigenic stimulus, possibly from an infection or through vaccination [13]. They further propose specifically that myelin basic protein (MBP) and other proteins constituting the myelin sheath are attacked by the immune system in both autism and MS. This has been recognized by many others in autism [14, 15] and MS [16–20]. In 1982, Weizman et al. reported a cell-mediated autoimmune response to human MBP in 76% of the autistic children studied [16]. Immune sensitization to the myelin sheath proteins could arise either through mimicry as a consequence of exposure of the immune system to a foreign antigen with a similar peptide sequence that is * Corresponding author. E-mail: seneff@csail.mit.edu Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases Anthony Samsel1 and Stephanie Seneff 2, * 1 Samsel Environmental and Public Health Services, Deerfield, NH 03037, USA 2 Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USA","PeriodicalId":88911,"journal":{"name":"Journal of biological physics and chemistry : JBPC","volume":"17 1","pages":"8-32"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"16","resultStr":"{\"title\":\"Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases\",\"authors\":\"Anthony Samsel, S. Seneff\",\"doi\":\"10.4024/25SA16A.JBPC.17.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"At first glance, multiple sclerosis (MS) and autism appear to have little in common, aside from the fact that both are neurological diseases. Autism is a condition with prenatal or early childhood onset, characterized by repetitive behaviours, impaired social interaction and cognitive impairment. The male:female ratio for autism is 4:1, while multiple sclerosis is twice as common in women as in men; its first symptoms usually begin in early adulthood to involve impaired lower limb mobility, although in later stages it affects both mental and physical capabilities. Both conditions are, however, associated with inflammatory autoimmune features [1, 2], and both diseases are viewed as having an environmental and a genetic component [3–6]. A study comparing a population of 658 MS patients with the general population found an association between MS and increased rates of asthma, inflammatory bowel disease (IBD), type 1 diabetes mellitus, pernicious anaemia and autoimmune thyroid disease [7], all of which have also been linked to autism [8–11]. These conditions are all considered to be autoimmune diseases, which can be triggered through molecular mimicry, where an antibody responding to a foreign protein that resembles a native protein becomes sensitized to the native protein as well [12]. A paper by Shoenfeld and Aron-Maor in 2000 developed the argument that both autism and MS may be examples of an autoimmune reaction via mimicry following exposure to an antigenic stimulus, possibly from an infection or through vaccination [13]. They further propose specifically that myelin basic protein (MBP) and other proteins constituting the myelin sheath are attacked by the immune system in both autism and MS. This has been recognized by many others in autism [14, 15] and MS [16–20]. In 1982, Weizman et al. reported a cell-mediated autoimmune response to human MBP in 76% of the autistic children studied [16]. Immune sensitization to the myelin sheath proteins could arise either through mimicry as a consequence of exposure of the immune system to a foreign antigen with a similar peptide sequence that is * Corresponding author. E-mail: seneff@csail.mit.edu Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases Anthony Samsel1 and Stephanie Seneff 2, * 1 Samsel Environmental and Public Health Services, Deerfield, NH 03037, USA 2 Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USA\",\"PeriodicalId\":88911,\"journal\":{\"name\":\"Journal of biological physics and chemistry : JBPC\",\"volume\":\"17 1\",\"pages\":\"8-32\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"16\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of biological physics and chemistry : JBPC\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4024/25SA16A.JBPC.17.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biological physics and chemistry : JBPC","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4024/25SA16A.JBPC.17.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16
摘要
乍一看,除了都是神经系统疾病外,多发性硬化症(MS)和自闭症似乎没有什么共同之处。自闭症是一种产前或儿童早期发病的疾病,其特征是重复行为、社交障碍和认知障碍。自闭症的男女比例是4:1,而多发性硬化症在女性中的发病率是男性的两倍;它的最初症状通常开始于成年早期,包括下肢活动能力受损,尽管在后期它会影响精神和身体能力。然而,这两种疾病都与炎症性自身免疫特征有关[1,2],并且这两种疾病都被认为具有环境和遗传成分[3-6]。一项将658名多发性硬化症患者与普通人群进行比较的研究发现,多发性硬化症与哮喘、炎症性肠病(IBD)、1型糖尿病、恶性贫血和自身免疫性甲状腺疾病[7]的发病率增加有关,而这些疾病也与自闭症有关[8-11]。这些情况都被认为是自身免疫性疾病,可以通过分子模仿引发,其中抗体对类似于天然蛋白质的外来蛋白质做出反应,并对天然蛋白质变得敏感。Shoenfeld和Aron-Maor在2000年发表的一篇论文提出,自闭症和多发性硬化症都可能是暴露于抗原刺激(可能来自感染或通过接种疫苗)后通过模仿产生的自身免疫反应的例子。他们进一步明确提出,髓鞘碱性蛋白(myelin basic protein, MBP)和其他构成髓鞘的蛋白在自闭症和多发性硬化症中都受到免疫系统的攻击,这一点在自闭症[14,15]和多发性硬化症[16-20]中得到了许多人的认可。1982年,Weizman等人报道了76%的自闭症儿童对人MBP的细胞介导的自身免疫反应。对髓鞘蛋白的免疫致敏可以通过免疫系统暴露于具有相似肽序列的外来抗原的模仿而产生*通讯作者。Anthony Samsel1和Stephanie Seneff 2, * 1 Samsel环境与公共卫生服务中心,Deerfield, NH 03037, USA 2麻省理工学院计算机科学与人工智能实验室,Cambridge, MA 02139, USA
Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases
At first glance, multiple sclerosis (MS) and autism appear to have little in common, aside from the fact that both are neurological diseases. Autism is a condition with prenatal or early childhood onset, characterized by repetitive behaviours, impaired social interaction and cognitive impairment. The male:female ratio for autism is 4:1, while multiple sclerosis is twice as common in women as in men; its first symptoms usually begin in early adulthood to involve impaired lower limb mobility, although in later stages it affects both mental and physical capabilities. Both conditions are, however, associated with inflammatory autoimmune features [1, 2], and both diseases are viewed as having an environmental and a genetic component [3–6]. A study comparing a population of 658 MS patients with the general population found an association between MS and increased rates of asthma, inflammatory bowel disease (IBD), type 1 diabetes mellitus, pernicious anaemia and autoimmune thyroid disease [7], all of which have also been linked to autism [8–11]. These conditions are all considered to be autoimmune diseases, which can be triggered through molecular mimicry, where an antibody responding to a foreign protein that resembles a native protein becomes sensitized to the native protein as well [12]. A paper by Shoenfeld and Aron-Maor in 2000 developed the argument that both autism and MS may be examples of an autoimmune reaction via mimicry following exposure to an antigenic stimulus, possibly from an infection or through vaccination [13]. They further propose specifically that myelin basic protein (MBP) and other proteins constituting the myelin sheath are attacked by the immune system in both autism and MS. This has been recognized by many others in autism [14, 15] and MS [16–20]. In 1982, Weizman et al. reported a cell-mediated autoimmune response to human MBP in 76% of the autistic children studied [16]. Immune sensitization to the myelin sheath proteins could arise either through mimicry as a consequence of exposure of the immune system to a foreign antigen with a similar peptide sequence that is * Corresponding author. E-mail: seneff@csail.mit.edu Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases Anthony Samsel1 and Stephanie Seneff 2, * 1 Samsel Environmental and Public Health Services, Deerfield, NH 03037, USA 2 Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USA